Photonics begins commercialization of stLase laser system for soft tissue surgery

In January 2013 Photonics, with investments from Maxwell Biotech Venture Fund and RVC Seed Fund, made ​​the first domestic sale of the laser system stLase known to the global market under the brand name Alta®. The company's development partner, Dental Photonics Inc., is engaged in the commercialization of the product in the global market and has placed over a dozen laser systems beginning in March 2012 in the United States and in Japan as of July 2012.  They also plan on selling in South Korea upon approval from the local regulator (KFDA).

"Photonics recent sales are very important news for our fund. StLase has become the first world-class innovative product developed with the participation of Maxwell Biotech Venture Fund, to enter both global and the Russian markets and is already being used to treat patients in the United States, Russia and Japan. We are confident that through the coordinated efforts of our international team that successfully completed the development and sale preparation of stLase, this device will hold a strong position in the competitive market of dental laser equipment,” said Dmitry Popov, Managing Partner of Maxwell Biotech Venture Fund.

"We are excited about commencement of commercial sales in the Russian Federation. This laser system features best-in class medical technology created over several years of intense collaboration with our Russian partners. The product’s unprecedented precision, speed, safety and ease of use have been enthusiastically received by top key opinion leaders in the U.S. We are pleased with the continued adoption of our products by top Russian clinicians and look forward to working with our international partners to establish a leading position in the medical laser instruments market,” said Alexander Vybornov, Dental Photonics’ CEO.

Alexey Teleshev, CEO of RVC Seed Fund added: "Photonics is a unique illustration of the global competitiveness of Russian technologies, developed in partnership with international experts. At the moment, the project has reached a major milestone and has started generating revenue as a result of the first sales in Russia and abroad."

StLase (Alta®) — is a compact laser system designed for various procedures and treatments on the soft tissues. The system consists of the main console, equipped with a 7-inch interactive touch screen, and the applicable modules that can be attached to the side of the console. Advantages of the new laser system include its compactness, multi-function capabilities, ergonomics, and the relatively low cost. The device can also be used in cardiovascular surgery, surgery in obstetrics and gynecology, ENT, proctology as well as other medical fields.

In late 2012, the developed design won two prestigious international awards: iF Product Design Award in 2013 and 2012 Good DesignTM.

 

Anna Zelenkova,
PR Director at Maxwell Biotech Group;
Tel.: +7 (495) 411-6992
E-mail: zelenkova@maxwellbiotech.ru